Adtalem Global Education Inc
ATGE
ISIN null / Valor 36832098
Adtalem Global Education Inc
UMushroom community rating:
About company
Adtalem Global Education Inc. is a prominent provider of educational services, primarily focused on the healthcare sector. The company operates several universities and offers a range of academic programs, certifications, and training aimed at addressing the evolving needs of the healthcare workforce. By partnering with various organizations, Adtalem seeks to facilitate career development and ensure that students and professionals are equipped with the necessary skills to succeed in the medical and healthcare industries. The company emphasizes a comprehensive approach to education, aiming to deliver quality learning experiences while maintaining transparency and responsibility in its operations. Through its initiatives, Adtalem plays a significant role in supplying talent to the healthcare industry, thereby contributing to the broader community's educational and professional landscape.
Summarized from source with an LLMView SourceSector: Business ServicesLatest Results (05.10.2025):
Adtalem Global Education Inc. announced strong financial results for the fourth quarter of fiscal year 2025, showcasing significant growth in revenue, enrollment, and earnings. The company achieved a 12.9% year-over-year increase in total revenue for the fiscal year, reflecting its robust operational performance and expanding student base.
Revenue Growth
For the fourth quarter of fiscal year 2025, Adtalem reported revenue of $457.1 million, an 11.5% increase compared to the same period last year. The fiscal year 2025 total revenue reached $1,788.3 million, up 12.9% year-over-year.
Enrollment Expansion
Total student enrollment increased by 10.2% year-over-year in the fourth quarter, reaching 91,780 students. Notably, Chamberlain University and Walden University continued their streak of enrollment growth, with Chamberlain up 5.8% and Walden up 15.0% compared to the previous year.
Enhanced Earnings
Fiscal year 2025 diluted earnings per share were $6.18, reflecting a 33.1% growth year-over-year. The adjusted earnings per share stood at $6.67, further demonstrating strong profitability and financial health.
Adjusted EBITDA Performance
Adjusted EBITDA for the fourth quarter was $110.2 million, marking a 13.2% increase year-over-year. For the entire fiscal year, adjusted EBITDA reached $459.7 million, up 21.8% compared to the previous year.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
3392 M
Market cap (USD)
755,592
Daily traded volume (Shares)
91.14 / 89.535
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
